Epidemiological and Clinicopathological Characteristics of Oral Tumors among Libyan Patients
DOI:
https://doi.org/10.54361/LJMR.20.1.13Keywords:
Oral tumors, Oral squamous cell carcinoma, Clinicopathological characteristics, LibyaAbstract
Background: Oral tumors comprise a wide spectrum of lesions with variable biological behavior and represent a significant health concern worldwide. In Libya, epidemiological and clinicopathological data on oral tumors remain scarce and fragmented. Methods: A retrospective observational study was conducted using medical and histopathological records of 152 patients diagnosed with oral tumors between April 2024 and December 2025. Data on age, sex, anatomical site, histopathological diagnosis, tumor nature (benign or malignant), and treatment modalities were collected and analyzed descriptively. Results: The mean age of patients was 46.3 ± 15.8 years, with a male predominance (61.8%) and a male-to-female ratio of 1.6:1. The most affected age group was 41–60 years. The tongue was the most common anatomical site (34.2%), followed by the gingiva and buccal mucosa. Malignant tumors accounted for 64.5% of cases, with oral squamous cell carcinoma being the predominant histopathological type. Benign tumors constituted 35.5% of cases and were mainly odontogenic, particularly ameloblastoma and odontoma. Surgical treatment was the primary management approach, with adjuvant therapy applied in selected malignant cases. Conclusion: Malignant oral tumors, particularly oral squamous cell carcinoma, were predominant among middle-aged male patients, with the tongue as the most frequently involved site. These findings highlight the importance of early diagnosis, histopathological confirmation, and timely surgical intervention, and emphasize the need for improved awareness and preventive strategies to reduce the burden of oral tumors in Libya.
Downloads
References
1. Neville BW, Damm DD, Allen CM, Chi AC. Oral and maxillofacial pathology. 4th ed. St. Louis: Elsevier; 2016.
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
3. Speight PM, Takata T. New tumour entities in the WHO classification of head and neck tumours. Virchows Arch. 2018;472(3):331–339.
4. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36(10):575–580.
5. Scully C, Porter S. Oral cancer. BMJ. 2001;321(7253):97–100.
6. Eltohami YI, Ben-Selma W, El-Shatshat AE. Patterns of oral and maxillofacial tumors in Libya: A retrospective institutional study. Afr Health Sci. 2019;19(2):2341–2348.
7. Smith J, Ahmed K, Hassan R, et al. Epidemiology of oral tumors in North Africa: A retrospective study. Oral Oncol. 2022;127:105682.
8. Warnakulasuriya S. Causes of oral cancer: An overview. Oral Dis. 2009;15(8):769–775.
9. Gupta B, Johnson NW, Kumar N. Global epidemiology of oral cancer: An overview. Oral Oncol. 2016;58:12–18.
10. Petersen PE. Oral cancer prevention and control – A global perspective. Med Oral Patol Oral Cir Bucal. 2012;17(1):e115–e119.
11. Ahmed R, Khalifa A, Mansour M, et al. Clinicopathological patterns of oral malignancies in the Mediterranean region. J Oral Maxillofac Surg. 2021;79(5):1123–1130.
12. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon: IARC Press; 2017.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Salwa Alwafi Abukhedir, Sarah Yousuf Alhameedi, Tebra Ramadan Abdulsalam (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
